论文著作：
1、K. Lv, S. Wu, W. Li, Y. Geng, M. Wu, J. Zhou, Y. Li, Q. Gao, M. Liu, Design, synthesis and anti-HBV activity of NVR3-778 derivatives, Bioorganic chemistry, 94 (2020) 103363.
2、K. Lv, W. Li, S. Wu, Y. Geng, A. Wang, L. Yang, M. Huang, K. Chowdhury, Y. Li, M. Liu, Amino acid prodrugs of NVR3-778: Design, synthesis and anti-HBV activity, Bioorganic & medicinal chemistry letters, 30 (2020) 127103.
3、H. Wang, K. Lv (Co-first author),, X. Li, B. Wang, A. Wang, Z. Tao, Y. Geng, B. Wang, M. Huang, M. Liu, H. Guo, Y. Lu, Design, synthesis and antimycobacterial activity of novel nitrobenzamide derivatives, Chinese Chemical Letters, 30 (2019) 413-416.
4、A. Wang, K. Lv (Co-first author),, Z. Tao, J. Gu, L. Fu, M. Liu, B. Wan, S.G. Franzblau, C. Ma, X. Ma, B. Han, A. Wang, S. Xu, Y. Lu, Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents, European journal of medicinal chemistry, 181 (2019) 111595.
5、A. Wang, K. Lv (Co-first author),, L. Li, H. Liu, Z. Tao, B. Wang, M. Liu, C. Ma, X. Ma, B. Han, A. Wang, Y. Lu, Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents, European journal of medicinal chemistry, 178 (2019) 715-725.
6、K. Lv, A. Wang, Z. Tao, L. Fu, H. Liu, B. Wang, C. Ma, H. Wang, X. Ma, B. Han, A. Wang, K. Zhang, M. Liu, Y. Lu, hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents, European journal of medicinal chemistry, 179 (2019) 208-217.
7、Z. Tao, R. Cao, Y. Yan, G. Huang, K. Lv*, W. Li, Y. Geng, L. Zhao, A. Wang, Q. He, J. Yang, S. Fan, M. Huang, H. Guo, W. Zhong, M. Liu, Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives, European journal of medicinal chemistry, 157 (2018) 994-1004.
8、K. Lv, Z. Tao, Q. Liu, L. Yang, B. Wang, S. Wu, A. Wang, M. Huang, M. Liu, Y. Lu, Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety, European journal of medicinal chemistry, 151 (2018) 1-8.
9、L. Li, K. Lv (Co-first author), Y. Yang, J. Sun, Z. Tao, A. Wang, B. Wang, H. Wang, Y. Geng, M. Liu, H. Guo, Y. Lu, Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents, ACS medicinal chemistry letters, 9 (2018) 741-745.
10、R. Zhang, K. Lv (Co-first author), B. Wang, L. Li, B. Wang, M. Liu, H. Guo, A. Wang, Y. Lu, Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety, Rsc Adv, 7 (2017) 1480-1483.
11、L. Tang, Z. Bei, Y. Song, L. Xu, H. Wang, D. Zhang, Y. Dou, K. Lv*, H. Wang, Synthesis and in vivo antimalarial activity of novel naphthoquine derivatives with linear/cyclic structured pendants, Future medicinal chemistry, 9 (2017) 1117-1127.
12、K. Lv, X. You, B. Wang, Z. Wei, Y. Chai, B. Wang, A. Wang, G. Huang, M. Liu, Y. Lu, Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents, ACS medicinal chemistry letters, 8 (2017) 636-641.
13、K. Lv, L. Li, B. Wang, M. Liu, B. Wang, W. Shen, H. Guo, Y. Lu, Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives, European journal of medicinal chemistry, 137 (2017) 117-125.
吕凯
北京市
研究领域：
生物医药
研究方向：
抗病毒、抗结核、以及抗耐药菌小分子的药物化学研究
所在单位：
中国医学科学院北京协和医学院
